DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/pklt4w/global_acne) has announced the addition of the "Global Acne Epidemiology and Patient Flow Analysis - 2012" report to their offering.
Fore Pharma announced the results of its Acne patient population study in a new report Global Acne Epidemiology and Patient Flow Analysis - 2012'. The report provides insights into Acne epidemiology, Acne diagnosed patients, and Acne treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Acne derived from epidemiological analysis, percentage of patients diagnosed with Acne, and percentage of patients treated with Acne therapy.
The study helps executives estimate Acne market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Acne prevalence, Acne diagnosis rate, and Acne treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.
Key Features of the Report:
- Acne: Disease Definition
- Acne Patient Flow
- Acne Prevalence
- Acne Diagnosed Patients
- Acne Treated Patients
For more information visit http://www.researchandmarkets.com/research/pklt4w/global_acne
Source: Research and Markets